Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 94Terminated 24Unknown 17Active not recruiting 7Withdrawn 3Recruiting 3Not yet recruiting 2Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Sarcoma 2Myeloid 2Gastrointestinal 2Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Myeloid, Chronic-Phase 1

Interventions

Specimen Handling 3Biopsy 3venetoclax 2selinexor 2luspatercept 2Tacrolimus 2Lymphatic Irradiation 2Imatinib Mesylate 2Busulfan 2Azacitidine 2trametinib 1tagraxofusp 1peginterferon alfa-2b 1olutasidenib 1nilotinib 1flumatinib 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1dabrafenib 1Tyrosine Kinase Inhibitors 1Thiotepa 1Spectroscopy, Near-Infrared 1Sirolimus 1Single-Cell Gene Expression Analysis 1Resistance Training 1Receptors, Antigen, T-Cell 1Quality of Life 1Pleurodesis 1Phlebotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Imatinib Mesylate × Myeloid × Clear all
NCT07413263 2026-02-18

Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

Assiut University

Not yet recruiting
75 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05367765 2022-05-10

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Phase 4 Not yet recruiting
2,400 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡